MedPath

Focused Incentive Spirometry Monitoring to Reduce Postoperative Oxygen Therapy and Respiratory Complications After Bariatric Surgery

Not Applicable
Completed
Conditions
Respiratory Complication
Registration Number
NCT03010852
Lead Sponsor
University of Colorado, Denver
Brief Summary

Postoperative (PO) hypoventilation, atelectasis and hypoxemia after bariatric surgery are common and multifactorial, contributing to prolonged oxygen (O2) therapy after surgery and even at hospital discharge. Incentive spirometry (IS) is recommended postoperatively but its success in preventing postoperative atelectasis and hypoxemia (POH) heavily depends on patient compliance with IS effort and frequency. The investigators hypothesize that a focused education preoperatively on IS for POH and intensive monitoring of patient compliance with IS therapy in the early postoperative period shortens postoperative oxygen therapy, decreases POH episodes, and improves respiratory outcomes after bariatric surgery, compared to patients receiving standard of care.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Patients having planned elective bariatric surgery at University of Colorado Hospital
Exclusion Criteria
  • Emergency procedure
  • Oxygen therapy within the previous 30 days
  • Smoking within the previous 30 days
  • Inability or refusal to provide consent

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Frequency of at least one episode of moderate/severe hypoxemic eventDuring first post operative day
Secondary Outcome Measures
NameTimeMethod
Presence of postoperative oxygen therapy and postoperative hypoxemic eventsUp to 7 days after surgery

The development of postoperative hypoxemic events will be evaluated from the initiation of post-operative oxygen therapy through hospital discharge.

Duration of postoperative oxygen therapyUp to 7 days after surgery

The duration of postoperative oxygen therapy will be evaluated from the arrival to the post-anesthesia care unit to successful discontinuation of oxygen therapy lasting greater than 2 hours.

Trial Locations

Locations (1)

University of Colorado Hospital

🇺🇸

Aurora, Colorado, United States

University of Colorado Hospital
🇺🇸Aurora, Colorado, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.